Oss, Netherlands

Paul Peter Marie Antonius Dols


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Paul Peter Marie Antonius Dols

Introduction

Paul Peter Marie Antonius Dols is a notable inventor based in Oss, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of non-steroidal progesterone receptor modulators. His work has implications for various therapeutic applications, showcasing his expertise and innovative spirit.

Latest Patents

Dols holds a patent for "Non-steroidal progesterone receptor modulators." This invention provides compounds according to general Formula (I), including a prodrug thereof, a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable salt of a prodrug thereof. More specifically, the invention offers high-affinity non-steroidal compounds that act as agonists, partial agonists, or antagonists of the progesterone receptor. This patent highlights Dols' commitment to advancing medical science through innovative solutions.

Career Highlights

Dols is associated with N.V. Organon, a company known for its focus on pharmaceuticals and healthcare. His role at Organon has allowed him to contribute to groundbreaking research and development in the field. His work has not only advanced the understanding of progesterone receptors but has also paved the way for new therapeutic options.

Collaborations

Dols has collaborated with esteemed colleagues such as Pedro Harold Han Hermkens and Hans Lucas. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the impact of their collective work.

Conclusion

Paul Peter Marie Antonius Dols is a distinguished inventor whose contributions to the field of pharmaceuticals are noteworthy. His patent on non-steroidal progesterone receptor modulators exemplifies his innovative approach to solving complex medical challenges. Through his work at N.V. Organon and collaborations with fellow researchers, Dols continues to make significant strides in advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…